Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ImmuCell Corp ICCC

Healthcare Biotechnology
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which... see more

Recent & Breaking News (NDAQ:ICCC)

ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021

GlobeNewswire October 6, 2021

Raffael Lichdi, DVM Joins ImmuCell's Sales & Marketing Team

GlobeNewswire September 14, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC

Newsfile September 2, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC

Newsfile August 25, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC

PR Newswire August 24, 2021

ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®

GlobeNewswire August 24, 2021

ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021

GlobeNewswire August 12, 2021

ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021

GlobeNewswire August 5, 2021

ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021

GlobeNewswire July 7, 2021

ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

GlobeNewswire May 19, 2021

ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021

GlobeNewswire May 13, 2021

ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021

GlobeNewswire May 6, 2021

ImmuCell Closes $4,250,000 Equity Financing

GlobeNewswire April 14, 2021

ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021

GlobeNewswire April 7, 2021

ImmuCell Makes Important Regulatory Submission and Announces Unaudited Financial Results for the Year Ended December 31, 2020

GlobeNewswire February 22, 2021

ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020

GlobeNewswire February 16, 2021

ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020

GlobeNewswire January 7, 2021

ImmuCell Announces Restructuring of its Bank Debt

GlobeNewswire December 15, 2020

ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020

GlobeNewswire November 12, 2020

ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2020

GlobeNewswire November 5, 2020